Across six asthma biologics, adherence differed by the therapy given and was often low or irregular based on three adherence measures, according to a presentation here.This cross-sectional cohort ...
Mumbai: GlaxoSmithKline Pharmaceuticals Limited has announced the appointment of Carson Dalton as Executive Vice President, ...
Net Sales at Rs 949.42 crore in December 2024 up 17.9% from Rs. 805.26 crore in December 2023. Quarterly Net Profit at Rs.
Despite multiple lawsuits filed by state attorneys general and a temporary block imposed by a federal judge, many ...
NEW YORK, NY / ACCESS Newswire / March 3, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers ...
The Indian stock market faces pressure from foreign capital outflow and economic weakness, with Nifty 50 down 15.82% since ...
GSK, Amgen and AstraZeneca released positive data supporting their rival drugs in a condition called chronic rhinosinusitis ...
Emerging tools enable more accurate antigen production and presentation using mRNA instead of protein. In recent years, mRNA technology has come into its own, most prominently in the field of vaccine ...
Everyone is talking about or using weight loss products. So, the government pounces. A batch of 17 drugs are on a list of ...
The US Food and Drug Administration (FDA) has accepted for review GSK’s Biologics License Application for depemokimab.
FDA reviews GSK depemokimab for asthma and CRSwNP, with a decision expected by December 2025. Phase 3 data shows improvements ...
Already billed as a potential blockbuster, Amgen and AstraZeneca’s Tezspire has turned in strong clinical data in chronic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback